Today: 29 April 2026
Browse Category

NYSE:DGX 29 July 2025 - 4 December 2025

Hims & Hers (HIMS) Stock Jumps on Canada Launch and YourBio Deal: Latest News, Forecasts and Analysis for December 4, 2025

Hims & Hers (HIMS) Stock Jumps on Canada Launch and YourBio Deal: Latest News, Forecasts and Analysis for December 4, 2025

Hims & Hers shares jumped about 8% Thursday to $40.19 after announcing a Canada launch, backed by its Livewell acquisition. The company also agreed to buy YourBio Health and recently launched a diagnostics platform with Quest Diagnostics. Market cap stands near $12.8 billion. Short interest remains high, with 67.6 million shares sold short, or about 36% of the float.
4 December 2025
···
Hims & Hers Health (HIMS) Stock Falls as New ‘Labs’ Platform With Quest Diagnostics Launches – November 14, 2025 Update

Hims & Hers Health (HIMS) Stock Falls as New ‘Labs’ Platform With Quest Diagnostics Launches – November 14, 2025 Update

Hims & Hers Health shares fell about 7–8% to $36.05 Friday after launching its new Labs diagnostic platform with Quest Diagnostics. The company’s market cap stands near $8.2 billion. Labs offers nationwide blood testing and health monitoring through annual subscriptions. The stock remains up roughly 43% year-to-date but trades well below its 52-week high.
14 November 2025
··
AI Just Diagnosed You—Now What? The Rise of Superhuman Doctors Made of Code

AI Just Diagnosed You—Now What? The Rise of Superhuman Doctors Made of Code

An AI chatbot diagnosed a U.S. boy’s chronic pain as spina bifida occulta after 17 doctors failed; a specialist confirmed the result. Microsoft’s MAI-DxO correctly diagnosed 85% of nearly 300 complex cases, far surpassing physicians. By October 2024, the FDA had cleared over 1,000 AI medical devices, mainly for radiology, but no generative AI system had full approval as a medical device.
29 July 2025
····

Stock Market Today

  • VTI Falls 0.3% as PLTR Stock Declines Amid Heavy Insider Selling
    April 29, 2026, 2:24 PM EDT. VTI, the Vanguard Total Stock Market ETF, dropped 0.3% today, weighed down by a 3.4% decline in Palantir Technologies (PLTR) shares. Notable VTI holdings like Nvidia (-1.2%), Microsoft (-1.2%), and Apple (-0.8%) also contributed to losses. PLTR insiders have sold 227 times in six months without any purchases, including major sales by Peter Thiel and CEO Alexander Karp, signaling potential negative sentiment. Despite recent analyst buy ratings from Mizuho, Citigroup, and others, RBC Capital issued an underperform rating. Investors can monitor PLTR's insider activity and analyst outlook via Quiver Quantitative's dashboards. The median PLTR price target remains incomplete in reports, further highlighting investor uncertainty.

Latest article

Why Rising Dragon Acquisition Stock Surged as RDAC Seeks More Time for HZJL SPAC Deal

Why Rising Dragon Acquisition Stock Surged as RDAC Seeks More Time for HZJL SPAC Deal

29 April 2026
Rising Dragon Acquisition Corp. shares surged over 400% to $21.72 Wednesday after the SPAC proposed extending its merger deadline with HZJL Cayman Limited. The company called a May 28 shareholder meeting to vote on extending the deadline by up to 15 months. Rising Dragon’s board urged shareholders to approve the extension. The HZJL merger has not closed.
Upstart Stock Falls After $1.25 Billion Fortress Deal: Why Investors Are Still Wary

Upstart Stock Falls After $1.25 Billion Fortress Deal: Why Investors Are Still Wary

29 April 2026
Upstart Holdings shares fell $2.09 to $30.77 Wednesday after announcing Fortress Investment Group affiliates will buy up to $1.25 billion in consumer loans over 15 months. March loan originations rose 60% year over year to $1.263 billion. In 2025, Upstart’s revenue climbed 64% to $1.0 billion, with net income of $53.6 million after a $129 million loss in 2024. Upstart plans to apply for a national bank charter.
Intel Stock Hits Record High as Google AI Chip Report Puts Foundry Turnaround in Play

Intel Stock Hits Record High as Google AI Chip Report Puts Foundry Turnaround in Play

29 April 2026
Intel shares surged 10% Wednesday after reports that Google may use Intel’s EMIB chip-packaging technology in its next AI processor. The stock hit $94.03 before settling at $93.23. Intel recently reported first-quarter revenue of $13.6 billion, up 7% year over year. CFO David Zinsner said some gains came from selling previously shelved chips.
Go toTop